Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-25-011859
Filing Date
2025-05-02
Accepted
2025-05-02 18:19:16
Documents
1
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 form4a-05022025_100513.html 4/A  
1 form4a-05022025_100513.xml 4/A 7353
  Complete submission text file 0001415889-25-011859.txt   8992
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5956 SHERRY LN 1810 DALLAS TX 75225
Business Address
HALL WALLACE L JR (Reporting) CIK: 0001762801 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36279 | Film No.: 25910370